| |
| |
|
| Insider
Information: |
Bhatt Padmanabh P. |
| Relationship: |
Sr. VP of IP, CSO |
| City: |
Rockville |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
8,570 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$257,700 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
8,570 |
|
|
| Total
Value |
$257,700 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Supernus Pharmaceuticals Inc |
SUPN |
Sr. VP of IP, CSO |
2024-03-21 |
8,570 |
2012-06-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SUPN |
Supernus Pharmaceuticals ... |
Sr. VP of IP, CSO |
• – – |
2024-03-21 |
4 |
AS |
$35.31 |
$511,677 |
D/D |
(14,491) |
8,570 |
0 |
% |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. VP of IP, CSO |
• – – |
2024-03-21 |
4 |
OE |
$25.30 |
$366,622 |
D/D |
14,491 |
23,061 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. VP of IP, CSO |
• – – |
2024-03-20 |
4 |
AS |
$35.31 |
$14,124 |
D/D |
(400) |
8,570 |
0 |
% |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. VP of IP, CSO |
• – – |
2024-03-20 |
4 |
OE |
$25.30 |
$10,120 |
D/D |
400 |
8,970 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. VP of IP, CSO |
• – – |
2024-03-19 |
4 |
AS |
$35.31 |
$436,573 |
D/D |
(12,364) |
8,570 |
0 |
% |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. VP of IP, CSO |
• – – |
2024-03-19 |
4 |
OE |
$25.30 |
$312,809 |
D/D |
12,364 |
20,934 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. VP of IP, CSO |
• – – |
2024-03-13 |
4 |
AS |
$33.48 |
$2,104,289 |
D/D |
(62,366) |
8,570 |
0 |
% |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. VP of IP, CSO |
• – – |
2024-03-13 |
4 |
OE |
$12.98 |
$1,098,523 |
D/D |
62,366 |
44,686 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. VP of IP, CSO |
• – – |
2024-03-12 |
4 |
OE |
$12.98 |
$50,414 |
D/D |
3,884 |
12,454 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. VP of IP, CSO |
• – – |
2024-03-12 |
4 |
AS |
$32.99 |
$128,133 |
D/D |
(3,884) |
8,570 |
0 |
% |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. VP of IP, CSO |
• – – |
2024-02-26 |
4 |
AS |
$30.21 |
$151,050 |
D/D |
(5,000) |
8,570 |
0 |
% |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. VP of IP, CSO |
• – – |
2024-02-26 |
4 |
OE |
$9.13 |
$45,650 |
D/D |
5,000 |
13,570 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. VP of IP, CSO |
• – – |
2024-02-23 |
4 |
D |
$29.06 |
$18,540 |
D/D |
(638) |
8,570 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. VP of IP, CSO |
• – – |
2024-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
1,250 |
9,208 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. VP of IP, CSO |
• – – |
2024-02-22 |
4 |
D |
$27.94 |
$10,394 |
D/D |
(372) |
7,958 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. VP of IP, CSO |
• – – |
2024-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
750 |
8,330 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. VP of IP, CSO |
• – – |
2023-09-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,500 |
8,347 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. VP of IP, CSO |
• – – |
2023-09-07 |
4 |
D |
$32.10 |
$37,942 |
D/D |
(1,182) |
7,165 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. VP of IP, CSO |
• – – |
2023-05-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
750 |
5,497 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. VP of IP, CSO |
• – – |
2023-04-11 |
4 |
A |
$0.00 |
$0 |
D/D |
1,500 |
4,747 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. VP of IP, CSO |
• – – |
2023-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
750 |
3,247 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. VP of IP, CSO |
• – – |
2023-01-17 |
4 |
AS |
$39.92 |
$192,638 |
D/D |
(4,826) |
1,644 |
0 |
% |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. VP of IP, CSO |
• – – |
2023-01-17 |
4 |
OE |
$9.13 |
$44,061 |
D/D |
4,826 |
6,470 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. VP of IP, CSO |
• – – |
2023-01-06 |
4 |
OE |
$9.13 |
$1,589 |
D/D |
174 |
1,818 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
Sr. VP of IP, CSO |
• – – |
2023-01-06 |
4 |
AS |
$39.90 |
$6,943 |
D/D |
(174) |
1,644 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
